Sleep apnea and congestive heart failure

Area of Science:

• Cardiology
• Pulmonology
• Sleep Medicine

Background:

• Sleep apnea, encompassing obstructive and central types, is highly prevalent in patients with congestive heart failure (CHF).
• Both sleep apnea types share distinct etiologies but contribute to cardiac dysfunction progression in heart failure.
• Obstructive sleep apnea is an independent risk factor for cardiac disease, while central sleep apnea can worsen existing heart failure.

Purpose of the Study:

• To review mechanistic, epidemiological, and interventional studies on the relationship between sleep apnea and congestive heart failure.
• To discuss the impact of sleep apnea on cardiac dysfunction and the potential benefits of its treatment in heart failure patients.
• To provide commentary on future research directions in this rapidly evolving field.

Main Methods:

• Systematic review of mechanistic data, epidemiological findings, and randomized controlled trials.
• Analysis of studies investigating the effects of sleep apnea therapies on cardiac function, symptoms, and sympathetic activity.
• Inclusion of data from ongoing large-scale mortality trials.

Main Results:

• Mechanistic data link both obstructive and central sleep apnea to the progression of cardiac dysfunction in heart failure.
• Epidemiological studies suggest obstructive sleep apnea as an independent risk factor for heart disease.
• Interventional trials indicate that treating sleep apnea can improve symptoms, reduce sympatho-excitation, and enhance left ventricular function in CHF patients.

Conclusions:

• Sleep apnea is a significant comorbidity in congestive heart failure, impacting cardiac health through various mechanisms.
• Therapeutic interventions for sleep apnea demonstrate potential benefits for secondary endpoints in heart failure patients.
• Further research, including mortality trials, is crucial to fully elucidate the long-term impact of sleep apnea treatment in CHF.